MNG:LSEM&G Plc Analysis
Data as of 2026-03-14 - not real-time
£295.90
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Valuation appears attractive with a forward P/E of 9.5x versus an industry average of 16.4x, and the DCF model suggests the stock is trading within a few percent of its fair value. Revenue is expanding at a robust 37% YoY and operating margins remain healthy at 48%, yet the dividend yield of 7.07% is supported by a payout ratio of 286%, raising concerns about sustainability. The share price of 295.9p sits above the 30‑day support of 284.2p but below the 52‑week high of 324.5p, indicating limited upside in the near term.
Technical signals are mixed: the 20‑day SMA (309.7p) and 50‑day SMA (306.3p) are both above the current price, while the 200‑day SMA (273.3p) remains well below, hinting at a longer‑term bullish bias. However, the MACD is bearish (line –3.11 vs signal –0.48) and the RSI sits at 41, suggesting modest downside momentum. Volume trends are increasing, volatility is elevated at 24% over the past 30 days, and beta is low (0.4), implying the stock is less sensitive to market swings but still subject to sector‑specific risks.
Technical signals are mixed: the 20‑day SMA (309.7p) and 50‑day SMA (306.3p) are both above the current price, while the 200‑day SMA (273.3p) remains well below, hinting at a longer‑term bullish bias. However, the MACD is bearish (line –3.11 vs signal –0.48) and the RSI sits at 41, suggesting modest downside momentum. Volume trends are increasing, volatility is elevated at 24% over the past 30 days, and beta is low (0.4), implying the stock is less sensitive to market swings but still subject to sector‑specific risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- RSI below 50 indicating limited upside
- High dividend payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong 37% revenue growth
- Forward P/E well below industry average
- Recent dividend increase signaling confidence
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable operating margins but high net debt
- Regulatory pressures on pension and annuity products
- Low beta suggesting resilience to market volatility
Key Metrics & Analysis
Financial Health
Revenue Growth37.00%
Profit Margin4.11%
P/E Ratio9.5
ROE9.64%
ROA0.85%
Debt/Equity216.81
P/B Ratio224.7
Op. Cash Flow£953.0M
Free Cash Flow£-3572875008
Industry P/E16.4
Technical Analysis
TrendBullish
RSI41.1
Support£284.17
Resistance£324.50
MA 20£309.68
MA 50£306.34
MA 200£273.27
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value£963.47
Target Price£289.94
Upside/Downside-2.01%
GradeFair
TypeGrowth
Dividend Yield7.07%
Risk Assessment
Beta0.39
Volatility24.27%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.